According to MHRA product information, constipation is very common (affecting more than 1 in 10 people) with higher doses used for weight management (Wegovy, Saxenda), while it is common (affecting up to 1 in 10 people) with doses typically used for diabetes (Ozempic, Victoza)
They combine modalities to address fat reduction, body contouring for loose skin, and muscle toning
Activity & rest: Pair appropriate movement with real recovery time and avoid overtraining during an injury-recovery phase
We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions
The Food and Drug Administration recognizes this